Nebenwirkungen · Levetiracetam Actavis
Levetiracetam Actavis 250 mg film-coated tablets Levetiracetam Actavis 500 mg film-coated tablets Levetiracetam Actavis 750 mg film-coated tablets Levetiracetam Actavis 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-215379 · Präparat HOS-155426
Adverse reactions reported in clinical studies (adults, adolescents, children and infants >1 month) and from post-marketing experience are listed in the following table per System Organ Class and per frequency. Adverse reactions are presented in the order of decreasing seriousness and their frequency is defined as follows: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100); rare (≥1/10000 to <1/1000) and very rare (<1/10000).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-26T11:59:00Z · SHA-256 916ec26b98afabaca46e661dbea86bf6238c924e4065aa7e8dde03fecd868db3 · Passage 4f092bf9508b84d44e6cbe6817c0668042b3bf04b29305e92376554103cdaa5a · Zeichen 682–1136 im Abschnitt